Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis

The Breast - Tập 54 - Trang 203-210 - 2020
Paul Stewart1, Phillip Blanchette1, Prakesh S. Shah2,3, Xiang Y. Ye3, R. Gabriel Boldt4, Ricardo Fernandes1, Ted Vandenberg1, Jacques Raphael1
1Department of Oncology, Division of Medical Oncology, The University of Western Ontario, London, ON, Canada
2Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
3Department of Pediatrics, Mount Sinai Hospital, Toronto, ON, Canada
4London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Breast

Tập 54

203-210

Thông tin tác giả